5G-PEARL: Paxalisib in Malignant Brain Tumours | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
5G-PEARL: Paxalisib in Malignant Brain Tumours	Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor	Recruiting	Phase 1 / Phase 2	2026-02-05		NCT07391215

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Cambridge University Hospitals NHS Foundation Trust	64
Cancer Research UK	59
Institute of Cancer Research, United Kingdom	59
Kazia Therapeutics Limited	5
Minderoo Foundation	4
Royal Marsden NHS Foundation Trust	89

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Royal Marden NHS Foundation Trust	Sutton	United Kingdom	1